Company intelligence / Profile preview

Immune Insight

Lille, Hauts-de-France, Franceimmune-insight.com ↗

Ownership: Private
Development stage: Commercial

Overview

Immune Insight is a specialized CRO providing ex-vivo and in-vivo assessment of compounds on the immune system, with particular expertise in regulatory T cell analysis. They offer comprehensive immunological profiling to support drug discovery and development for pharma and biotech clients. The company does not have its own clinical pipeline but supports client programs from early preclinical through to clinical trials.

Therapeutic areas: OncologyImmunology
Modalities: Small moleculeBiologic
Industry: Contract Research Organization

Partnerships

Member of Medicines Discovery Catapult’s CRO Network

Beyond the preview

Go deeper on Immune Insight.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune Insight.

Explore the full profile